<VariationArchive RecordType="classified" VariationID="156329" VariationName="NM_000552.5(VWF):c.221-977_532+7059del" VariationType="Deletion" Accession="VCV000156329" Version="2" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2023-02-07" DateCreated="2014-10-06" MostRecentSubmission="2016-08-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="166109" VariationID="156329">
      <GeneList>
        <Gene Symbol="VWF" FullName="von Willebrand factor" GeneID="7450" HGNC_ID="HGNC:12726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="5948877" stop="6124670" display_start="5948877" display_stop="6124670" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6058039" stop="6233835" display_start="6058039" display_stop="6233835" Strand="-" />
          </Location>
          <OMIM>613160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000552.5(VWF):c.221-977_532+7059del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6103315" stop="6111945" display_start="6103315" display_stop="6111945" variantLength="8631" positionVCF="6103314" referenceAlleleVCF="GAGACTCCGTCTCAAAAAATATATATATATATGTGTGTATATATACATATATATGTGTGTGTGTGTATACACGTGTGTGTATACACGTGTGTGTATACACACGTGTGTGTATACACACGTGTGTATATACATACACATATATGTGTATATACACATATGTGTGTATATACATATATGTGTATACACACACGTATATATATACACACATATGTGTATATACACATATATGTATACACACACACACACACACACACACACACACACACACACAGATCAATGGAATAGAATAGACACCCAGAGATAGAGCCAGTTGATATTTGACAAAGCTGACAAGAATATATACTAGGGAAAGGACACCCTCTTCAACAAATGTTGCTGGGAAAACTGGATTGCCATATGCAGAAGAATGAAACTGGACCCCTATCTCTCACCATATACAAAAAAAAATCAACTCAAGATGTATTAAAGACTTGAATGTAAGGTCTGAAACTATAAAAATCCTAGAAAAAAACCTTGGGAAAACTGTACTGGACATTGGCCTAGGCAAGGAATTTCTGACTAAGACTTCAAAAACACAGGCAACAAAAACAAAAATAGATAAATGAGACTTCATTAAACTAAAAATCTTCTGCACAGCAAAAGAAATCATCAACAGAGTGAAGAGACAGCTTGCAGAATGGAAGAAAATATTTGCAAACTTTTTCATCCAGCAAGAGACTAGTATCCAGAATACACAAGGAACTCAAACAACTCAACAACAATGAAAAATAACAAATAATATCAGCAAGAAGTGGGCAAAGGACATGAGTAGACATTTTTCAAAGGAAGACATACAAATATCTGACAGGAATGTGAAAAAAATGGTCAACATAACTTGTCATGAGAGAAATGCAAATTAAAACCACAATGAGATATCATCTTACCCTAGTCACAACGGTTATTATTAAAAAGACAGAAAATAACAGATGTTGGCAAGGATGAGGAAAAAGGGGAACTCTTACACACTGTTGGTGGGAATGTAAATGAGTACAACCTCTATGGAAAACAGTATGCAGATTTTTCAAAGAACTTTAAAAAAAAAAAAAATAGGACTGCCAGGCGCGGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGCGTATCACGAGGTCAGGAGTTTGAGACCAGCCTGGCCAACATGGTGAAACCCCGCCTCTACTAAAAAAATACAAAAGAAAAAAAAATGAGCCGGACGTGGTGACATGCGCCTGTAGTCCCAGCTACTCAGGAGTCTGAGGCAGGAGAATTGCTTGAACCCGGGAACTGGAGGTTGCAGTGAGCTGAGATCAGGCCACTGCACTCCAGCCTGGGCAACAGAGTGAGACTCTGTCTCGGAAAAAAAAAAAATATATAGGACTACCATTCAATCCAGCAATCCCACTACTGGATATCTACCCAAAGGAAAAGAAATCAATATATCAAAAATATACCTGCACTAGTATATTTATTGTGCATTATTCACAATAGCAAAGACATGGTATGAACCTAAATGCCCATCAACAGATGATTAGATGAAGAAAATGTGGTACATATACACAATGGAAGACTATTTGGCCATAAGAATGAAATCGCATCTTTTGCAGCAACATGGGTGGGATTGGAGGTCATTATGTTAAGTGAAACAAACCACATAAAGTCAAATATGACATGTTCTCACCAAAAAGTGGTTACTAAAAGATGTGTACACACAGACAGAAAGAGTAGAATGATAGATATTGGAGACTCAGAAAGGTGAGAGAGAGTGGGAGTGGGGCAGATGATGAGAAATTACTTAATGGGTACAAAGTATATTGTACCCTAAAAGTCCTGACTTGACCACTACACAATCTGTGCATGTAACAAAATTGCGCTTGTACCCCATAAATTTATACAATTTTTTTTTTGAGACAGAGTCTCGCTTTGTCACCCAGGCTAGAGTGCAGTGGGGCGATCTCGGCTCATTGCAACCTCCGTCCCCTGGGTTCAAGCAACTCTCCTGCCTCAGCCTCCCTAGTAGCTAGGATTACAGGCATGTGCTACCACCCCCAGCTAATTTTTATATTTTTAGTAGAGATGGGGTTTCACATGTTGGCCAGGCTGGTCTTGAACTTCTGACCTCAAATGATCCATCCACCTCGGCCTCCTGAAGTGCTGGGATTACAGGATTACAGGCGTGGGCCACCACGCCCGGCCTTATACAAATTTTTAAAAAGAAAAAATTTAAAAAATGTTTAAGAAGAAATTGCATATCAAATTTTTCTCCTTTTAAGTAAAGAGAAATAGATATTGTAAAAGGAATATTTTAAAATTTCACATACCTGAAAAATAAATCATGAAATATATGAAGAAAATAGAATTGCCATTAGAAATCATCCAGGAATTCTGCCTCTGGGAATATACTCAAAAGAATTGAGCCGGACGCGGTGGTTCATGCCTGTAATCCCAGCACTCTGGGAGGCCAAGGTGGGCAGATCAAGAGGTCAAGAGATGGAGACCCTCCTGGCCAACATGGTGAAACCCCATCTCTACTAAAAATACAAAAAAAAAAAAATTAGCTGTGCGTGGTGGCATGCGCCTGTAGTCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATCACTTGAACCCGGGAGGTGGAGGTTGCAGTAAGCCGAGATCAGGCCACTGCACTTCAGCCTGGCGACAGAGGGAAACTCCATCTCAAAAAAAATAAAGAAGAATTGAAAGCAGGGTTTTAAAGAGTTATTTGTACACCTATACTCATAGCAGCTTTATTCACTATAGGCAAAACGTGGAAGCAATCTAAGTGTCTACTGATGGATAAATGGATAAGCAAAGTACGTACGGTCTGTATGCACAATGAAATTTTTTTTCTTTTCCTCAAATTCCTCTGATACAATGGAATATTATTCATCCTTAAAAAGGAAGAAAATTCTGACATACACCACAACATGAATGAACCTTGAGGACATTATGCAAAGTGAAATAAGCCAGCCACAAAAAGACAAATGCTGTATGATTCCACTTATATGAGATACTTAGAGTAGTCAAAATCATAGACAGAAAGTAAAATGATGGTTTCCAGGAGCCCAGAGGGAAGAATGGGAAGTTATTGTGTAATGAATATAAAGTTTCAGTTCTGCAAGATGAAAAGAGTTCTGGAGATGGATGGTGGTGATGGTTGTACAACTACATGAATGTACCTGATACCACTGAACTATATACATAAAAATGGTTAAGATAATAAATTTTGGCCAGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTAAGCGGAGGCGGATCACCTGAGGTCAGGAGTTCAAGAGCAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAATTAGCTGGACATAGTAGCGGACACCTGTAATCCCAGCTACTAGGGAAGCTGAGACTGGAGAATTGCTTCAGCCCGGGAGGCGGAGGTTGGAGTGAGCTGAGATCACACCATTGCACTGCAGCCTGGGCAACAAGAGTGAAACTCCGACTCAAAAAAAAAAAAAAAAAAAAAAAAGATAGTAAATTTTATGTTACATGTATCATAGCACAATAAAAAATGCGGCGGGGTGTAGAAATCTATACACAAATGTTTACACTGGCTTTGTTCATAATTTTCCATAATTGGAAACAACAAAGCATCCTTCAACTGGTGAATGGGTAAACAAATTGTGGTAACTACTCCTTAGCAATAAATAGGAACAAACTACTGATACATGCACCAATATGGATTAACCTCTCACGGACCATGTTAAATGAAAGAAGCCAGACTTACAAGACTAAATACTGCAAATAGGGTATGATTACAGTCATATGAATTTTGGAAATATCAAGACTACAGAAACAGATAAAAGATCAGTGGCCACCAGGAGCTAGGAGTTGGGGGAAGATTTGACTACAAAGGAGCATGGTGATTTTGAGGGTGACAAAACTGTTCTATAGTTTGATTGTGGTGGTTACATGACTCTACGCTTTTGCGAAAACTCAGAGAACTGTATGTGAAAGGGTGAATTTTACTGTCTGTAAATTAACCTCAATAAATCTGACTTTTGAAAGAACAATAATAAAATAGAGCCATGTGGTGCTTCCATGACACACATCTGAAACAAAATCACATAGAAAGGTTGAAAGAATGGAAAAAGATACATCAAACAAACACTAACCAAAAGAAAGGTGGAATAGCTATACTAATATCAGACAGATTGAAGGCAAAAAGCACTGGTAAAAATGAGAGTCATTACATTAAAGGAACAATTCCCTAGAAAGATTCAATATATATATATATATATTTTTTGAGACGGAGTCTCACTCTGTCGCCCAGGCTGGAGTGCAGTGGTGCGATTTCAGCTCACTGCAAGCTCCGCCTCCAAGGTTCATGCCATTCTCCTGCCTCAGCTTCCCGAGTAGCTGGGACTACAGGCACCTGCCACCACACCTGGCTCATTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCGTGGTAGCCAGGATAGTCTCCATCTCCTGACCTCATGATCCGCCCACTTCGGCCTCCCAAAGTGCTGGGATGACAGGCTTGAGCCACCGCACCCAGCCGAAAGATTCAGTATTTCTAAACACTAATAACAAAGGCTCAAGATATACAAAGCAGGCCAGGCACGGTGACTCACGCCTGTAATCCCAGCACTTTGGGAGGCAGAGGCGGAGAGATCACTTGAGGTCAGGAGTTCAAGACTAGCCTGGCCAACATGCTGAAACCTCATCTCTACTAAAAATACAAAAATTAGCCAGGCGTGGTGACACCTGGATGTAGTCCCAGCTACTCAGGAGGCTGAGGTAGAAGAATCGCTTGAATCTGGGAGGTGGAGGCTGTAGTGAGCTGAGATCTCACCACTGCAATCCGGCCTGGGTGACAGAGCAAGACTCTGTCTTTAAAAAAAAAAAAAAAGAAAGAAAGAAAGAAAGAAATATATACACACACACACACACACACACACACACACACAAAGCAAAATTTGACAGAATTACATGAAGAAAGTGACAAATTCACCACCATTATAGAAAAATTTAGCTCTTTTAGTAATGGGTCATTAATAAGCAGACAAGAAGTAGTACACATACAGAAGATCTGGAAAACACAATTAAAAAGCTTAATTCAAGAAGTATAGGTAGAGTCCTGCACCAATCAGAGAATACATTATTTTTGGGCATACATAGAACACTTGTAAAAAAAAAAAAAAAGGCTGCAAACAAGTCTACAATTTTTTAACTAGGCCACAATTTTTTAACCAAATTTAGAAATCAATTTAGTTACAAATAGGTAACTTTAAAAACTTCAGGCCAGGTACAGTGGCTCACACCTGTAAGCCCAGCACTTTGGGAGGCCGAGGGGGGCAGATCACGAGGTCAGGAGTTGGAGACCACCCTGGCTAACACAGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAGCCAGGCATGGTGGCGGGTGCCTGTAGTCCCAGCTACTCGGAAGGCTGAGGCAGGAGAATGGCGTGAACCCAGGAGGCAGAGCTTGCAGTGAGCCGAGATCGCGCCACTGCACTCCAGCCTGGGTGACAGAGCGAGACTCCGTCTCAAAAAAAAAAAAAAAAAAATTCAAACTTTTGAATTTGTAAATGTATATAGGTTCAGAAAGAGCTCAAAATGGAAGTTAGAAAATTTAAAACATGAAATATGTTACATATCAAAATTGGTACAGCTGGGCACAGTAACACACACCTATAATTCCACTAGGAAGGCTGAGGCAAGAGGATTCCTTGAGCCCAAGAGTTCAAGATCAGTTTGGGCAACTTAGCAAGACCTTATCTCTAAATACACACACACAGAGACACACAGACACACACACACACGTGTATATATATACATATATATACACACACATATATAATTACATATATACACACATATACAGTATATATACATATTTACACAAACACACACACATATATAGAGTGCAACTAAAGTGATATTTAGAGGGAAATTTATAGCCCTAAATGTACATATCAGACAATAAAATCAGTGCTGGAGAAAACCAAAAAATAAACTATCATGCTATTTTCCAATATGGTACATTCCAATGAAAGGAAGAGTCAATTGTTTCTCTGCATGTTTACTCTCTAATCAGAAAGTGGTTGGGTCATAAGGAAGAAAGATAACATATGTAAGTGTTTAGCTTTGGCAAGGGAACATCACTAATTGAATGTTTATGTAATTGAAATTAAAGAAGATTGAAATATTCATCTTTAGTGTTTTCTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCCAGGCTGGAGTGAAGCGGCACGATCACTGCTCACTGCAAGTTCTCCCTCCCGGGTTCACGCCATTCTCCTGTCTCAGCCTCCCAAGTAGCTGGAACTACAGGCACCCGCCACCACGCCTGGCTAATTTTCTGTATTTTTAGTAGAGACATGGTTTCACCATGTTAGCCAGGATGGTCTCAATCTCCTGACCTCATGATCCGCCTGCCTCGGCCTCCCAAAATGCTGGGATTACAGGGGTAAGCCACTGCGCCCAGCCTAGTGTTTTCACATTATCCATATTACTTTCTATTGCTCGTGAACACACACATGCACACACACATAAACTGGCCTTTTTGGATGGTGTGGAGGACCGACCACTCCATAGATTTTATCCACTCCACTGTAGTGGGCTGAGGAGGATCGACTCAAACTACCCAGCATTGACCAACCATCTGCCACGTGCAAGTTGCTACAGAGAATTCAAAGTTGAACGAAGTCAGCTTTGAGGAGCTCTAAGACCTGGTTTCACTAGAGGTCTAGGCATTGGAATGGAATGCAAAGAGATAAGGTTGGCAACATAAATTGAGGTGAGGTCACAGTGAGGCTTGAATGCCAGGGAAGGCATGTTAGTGAAGGTTTATGAGCAAGGAAATAAAAAGCATGGCCACACTTTAGGGAAATGGTATCCCAGAACATCTTACCTTCTTGGGTCATAAAGTCATCTTCAGCAAAGATGTTAAAGTTGCCACACAGCCCGCAGGTCTTGTTGAAGTATCTGTCTGACAGCAGGACTTGAAAGTTGCCGCTGCCATCGATCCTGGCCACAAAGCCATAGGCCTCACCGGACAGCTTGTAGTACCCAGCCTCAGTTTCTAGATACAGCCCTTTGGAGGCATAGGGCATGGAGACTCTGGAGGGCAAAGGCTAAGTTCAGAAGTGGGCTTCTTGTGCATTTTCTGGATGTCTCTCCCACCTTCTAACCCCAACCCCATGTTGTAGGGTTCAGAACATGGTGCAAAGTGGCTGAGGACCTAGATCAGCAATCGGGAGAGCTGGCTCTCACCCAGCCCTGCTACTCACTTCCTTGGAACATTTGCTTCCATTCTCTGGGCCCCAGCTTCCTCATCTAAAAATGAGGGGGTTGTGTCAGGGGATCCCTAGGGTCCTTTCTAACTCAGACATTGTTGGCTTACCTTTGGTCCCCCTGTGTCACGGTACCATTGACAAACAAATGGATGTCAAAAAATTCCCCAAGATACACGGAGAGGCTCACTCTCTTGCCATTCTGGAAGTCCCCTGAAAGAGAAAAAAGTCAATAGTAGTGATTATTACTCCTCTCAAAAAATGAATACATTGATTAAGAATCATTATCTACGTAACCTTTTCTCAGCAGAAAACGCCCCAAAAAGTCTTTACAAGCGAGCAACAAAAATCTCCCTAAAAATCTCATTTTCTCACCCATTTTTCCATTCATCTAAAAATAATTATTGAGTGACTTCTGGATACATTGCCCTCAGGTAGGCTCTCAAACATCACAAAAGAAAAATCTAAAAGCATGATCTTTTGCTTCTGGGAGTTTACAACCTGCGTATAAATAGAAGACAAACATGCGACAATTGAGTATATTGTAAGGCAGCAAACAAAAAGGCAACACTGTGAGTTACTGGTAACAGGTGCTCTAGGAGAGTGTTATTTATTCATTCATTCATTCACTTATTGAGACAGGGTTGTGCTCTGTTGCCCAGGTTGGGGTGCAGTGATGTGAACATGGCTCGCTGCAGTTTCTGCCTCCTGGGCCCAGGTTATCCTCCCACCTCAGCCTCCAGGGTAACTGGGATCACAAGTATGTACCACCACATCCAGCTAATTTTTTTTTTCTTTTTGTAGAGACAAGATCTCACCGTGTCGCCCAGGCTGGTCTTGAGCTCCTTGGTGCGAGTAATTACAGGCATGAGCCACCCCGCTCTGGCCTAGCAGTGCTATTTAAAATGGTATCGGTCGAGTGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGTGGATCACGAGGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCGTCTCTACTAAAAATATGAAGAAAAAAAAAATTAGCCAGGCGAGGTGGCTGGCGTCTGTGGTCCCAGTTCTTTGGGAGGCTGAGGCAGAAGAACGGCGTGAACCCAGGAGGCGGAGCTTGCAGTGAGCGGAGATCGCGCCACTGCACTCCAGCCTGGGTGACAGAGCA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6212481" stop="6221111" display_start="6212481" display_stop="6221111" variantLength="8631" positionVCF="6212480" referenceAlleleVCF="GAGACTCCGTCTCAAAAAATATATATATATATGTGTGTATATATACATATATATGTGTGTGTGTGTATACACGTGTGTGTATACACGTGTGTGTATACACACGTGTGTGTATACACACGTGTGTATATACATACACATATATGTGTATATACACATATGTGTGTATATACATATATGTGTATACACACACGTATATATATACACACATATGTGTATATACACATATATGTATACACACACACACACACACACACACACACACACACACACAGATCAATGGAATAGAATAGACACCCAGAGATAGAGCCAGTTGATATTTGACAAAGCTGACAAGAATATATACTAGGGAAAGGACACCCTCTTCAACAAATGTTGCTGGGAAAACTGGATTGCCATATGCAGAAGAATGAAACTGGACCCCTATCTCTCACCATATACAAAAAAAAATCAACTCAAGATGTATTAAAGACTTGAATGTAAGGTCTGAAACTATAAAAATCCTAGAAAAAAACCTTGGGAAAACTGTACTGGACATTGGCCTAGGCAAGGAATTTCTGACTAAGACTTCAAAAACACAGGCAACAAAAACAAAAATAGATAAATGAGACTTCATTAAACTAAAAATCTTCTGCACAGCAAAAGAAATCATCAACAGAGTGAAGAGACAGCTTGCAGAATGGAAGAAAATATTTGCAAACTTTTTCATCCAGCAAGAGACTAGTATCCAGAATACACAAGGAACTCAAACAACTCAACAACAATGAAAAATAACAAATAATATCAGCAAGAAGTGGGCAAAGGACATGAGTAGACATTTTTCAAAGGAAGACATACAAATATCTGACAGGAATGTGAAAAAAATGGTCAACATAACTTGTCATGAGAGAAATGCAAATTAAAACCACAATGAGATATCATCTTACCCTAGTCACAACGGTTATTATTAAAAAGACAGAAAATAACAGATGTTGGCAAGGATGAGGAAAAAGGGGAACTCTTACACACTGTTGGTGGGAATGTAAATGAGTACAACCTCTATGGAAAACAGTATGCAGATTTTTCAAAGAACTTTAAAAAAAAAAAAAATAGGACTGCCAGGCGCGGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGCGTATCACGAGGTCAGGAGTTTGAGACCAGCCTGGCCAACATGGTGAAACCCCGCCTCTACTAAAAAAATACAAAAGAAAAAAAAATGAGCCGGACGTGGTGACATGCGCCTGTAGTCCCAGCTACTCAGGAGTCTGAGGCAGGAGAATTGCTTGAACCCGGGAACTGGAGGTTGCAGTGAGCTGAGATCAGGCCACTGCACTCCAGCCTGGGCAACAGAGTGAGACTCTGTCTCGGAAAAAAAAAAAATATATAGGACTACCATTCAATCCAGCAATCCCACTACTGGATATCTACCCAAAGGAAAAGAAATCAATATATCAAAAATATACCTGCACTAGTATATTTATTGTGCATTATTCACAATAGCAAAGACATGGTATGAACCTAAATGCCCATCAACAGATGATTAGATGAAGAAAATGTGGTACATATACACAATGGAAGACTATTTGGCCATAAGAATGAAATCGCATCTTTTGCAGCAACATGGGTGGGATTGGAGGTCATTATGTTAAGTGAAACAAACCACATAAAGTCAAATATGACATGTTCTCACCAAAAAGTGGTTACTAAAAGATGTGTACACACAGACAGAAAGAGTAGAATGATAGATATTGGAGACTCAGAAAGGTGAGAGAGAGTGGGAGTGGGGCAGATGATGAGAAATTACTTAATGGGTACAAAGTATATTGTACCCTAAAAGTCCTGACTTGACCACTACACAATCTGTGCATGTAACAAAATTGCGCTTGTACCCCATAAATTTATACAATTTTTTTTTTGAGACAGAGTCTCGCTTTGTCACCCAGGCTAGAGTGCAGTGGGGCGATCTCGGCTCATTGCAACCTCCGTCCCCTGGGTTCAAGCAACTCTCCTGCCTCAGCCTCCCTAGTAGCTAGGATTACAGGCATGTGCTACCACCCCCAGCTAATTTTTATATTTTTAGTAGAGATGGGGTTTCACATGTTGGCCAGGCTGGTCTTGAACTTCTGACCTCAAATGATCCATCCACCTCGGCCTCCTGAAGTGCTGGGATTACAGGATTACAGGCGTGGGCCACCACGCCCGGCCTTATACAAATTTTTAAAAAGAAAAAATTTAAAAAATGTTTAAGAAGAAATTGCATATCAAATTTTTCTCCTTTTAAGTAAAGAGAAATAGATATTGTAAAAGGAATATTTTAAAATTTCACATACCTGAAAAATAAATCATGAAATATATGAAGAAAATAGAATTGCCATTAGAAATCATCCAGGAATTCTGCCTCTGGGAATATACTCAAAAGAATTGAGCCGGACGCGGTGGTTCATGCCTGTAATCCCAGCACTCTGGGAGGCCAAGGTGGGCAGATCAAGAGGTCAAGAGATGGAGACCCTCCTGGCCAACATGGTGAAACCCCATCTCTACTAAAAATACAAAAAAAAAAAAATTAGCTGTGCGTGGTGGCATGCGCCTGTAGTCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATCACTTGAACCCGGGAGGTGGAGGTTGCAGTAAGCCGAGATCAGGCCACTGCACTTCAGCCTGGCGACAGAGGGAAACTCCATCTCAAAAAAAATAAAGAAGAATTGAAAGCAGGGTTTTAAAGAGTTATTTGTACACCTATACTCATAGCAGCTTTATTCACTATAGGCAAAACGTGGAAGCAATCTAAGTGTCTACTGATGGATAAATGGATAAGCAAAGTACGTACGGTCTGTATGCACAATGAAATTTTTTTTCTTTTCCTCAAATTCCTCTGATACAATGGAATATTATTCATCCTTAAAAAGGAAGAAAATTCTGACATACACCACAACATGAATGAACCTTGAGGACATTATGCAAAGTGAAATAAGCCAGCCACAAAAAGACAAATGCTGTATGATTCCACTTATATGAGATACTTAGAGTAGTCAAAATCATAGACAGAAAGTAAAATGATGGTTTCCAGGAGCCCAGAGGGAAGAATGGGAAGTTATTGTGTAATGAATATAAAGTTTCAGTTCTGCAAGATGAAAAGAGTTCTGGAGATGGATGGTGGTGATGGTTGTACAACTACATGAATGTACCTGATACCACTGAACTATATACATAAAAATGGTTAAGATAATAAATTTTGGCCAGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTAAGCGGAGGCGGATCACCTGAGGTCAGGAGTTCAAGAGCAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAATTAGCTGGACATAGTAGCGGACACCTGTAATCCCAGCTACTAGGGAAGCTGAGACTGGAGAATTGCTTCAGCCCGGGAGGCGGAGGTTGGAGTGAGCTGAGATCACACCATTGCACTGCAGCCTGGGCAACAAGAGTGAAACTCCGACTCAAAAAAAAAAAAAAAAAAAAAAAAGATAGTAAATTTTATGTTACATGTATCATAGCACAATAAAAAATGCGGCGGGGTGTAGAAATCTATACACAAATGTTTACACTGGCTTTGTTCATAATTTTCCATAATTGGAAACAACAAAGCATCCTTCAACTGGTGAATGGGTAAACAAATTGTGGTAACTACTCCTTAGCAATAAATAGGAACAAACTACTGATACATGCACCAATATGGATTAACCTCTCACGGACCATGTTAAATGAAAGAAGCCAGACTTACAAGACTAAATACTGCAAATAGGGTATGATTACAGTCATATGAATTTTGGAAATATCAAGACTACAGAAACAGATAAAAGATCAGTGGCCACCAGGAGCTAGGAGTTGGGGGAAGATTTGACTACAAAGGAGCATGGTGATTTTGAGGGTGACAAAACTGTTCTATAGTTTGATTGTGGTGGTTACATGACTCTACGCTTTTGCGAAAACTCAGAGAACTGTATGTGAAAGGGTGAATTTTACTGTCTGTAAATTAACCTCAATAAATCTGACTTTTGAAAGAACAATAATAAAATAGAGCCATGTGGTGCTTCCATGACACACATCTGAAACAAAATCACATAGAAAGGTTGAAAGAATGGAAAAAGATACATCAAACAAACACTAACCAAAAGAAAGGTGGAATAGCTATACTAATATCAGACAGATTGAAGGCAAAAAGCACTGGTAAAAATGAGAGTCATTACATTAAAGGAACAATTCCCTAGAAAGATTCAATATATATATATATATATTTTTTGAGACGGAGTCTCACTCTGTCGCCCAGGCTGGAGTGCAGTGGTGCGATTTCAGCTCACTGCAAGCTCCGCCTCCAAGGTTCATGCCATTCTCCTGCCTCAGCTTCCCGAGTAGCTGGGACTACAGGCACCTGCCACCACACCTGGCTCATTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCGTGGTAGCCAGGATAGTCTCCATCTCCTGACCTCATGATCCGCCCACTTCGGCCTCCCAAAGTGCTGGGATGACAGGCTTGAGCCACCGCACCCAGCCGAAAGATTCAGTATTTCTAAACACTAATAACAAAGGCTCAAGATATACAAAGCAGGCCAGGCACGGTGACTCACGCCTGTAATCCCAGCACTTTGGGAGGCAGAGGCGGAGAGATCACTTGAGGTCAGGAGTTCAAGACTAGCCTGGCCAACATGCTGAAACCTCATCTCTACTAAAAATACAAAAATTAGCCAGGCGTGGTGACACCTGGATGTAGTCCCAGCTACTCAGGAGGCTGAGGTAGAAGAATCGCTTGAATCTGGGAGGTGGAGGCTGTAGTGAGCTGAGATCTCACCACTGCAATCCGGCCTGGGTGACAGAGCAAGACTCTGTCTTTAAAAAAAAAAAAAAAGAAAGAAAGAAAGAAAGAAATATATACACACACACACACACACACACACACACACACAAAGCAAAATTTGACAGAATTACATGAAGAAAGTGACAAATTCACCACCATTATAGAAAAATTTAGCTCTTTTAGTAATGGGTCATTAATAAGCAGACAAGAAGTAGTACACATACAGAAGATCTGGAAAACACAATTAAAAAGCTTAATTCAAGAAGTATAGGTAGAGTCCTGCACCAATCAGAGAATACATTATTTTTGGGCATACATAGAACACTTGTAAAAAAAAAAAAAAAGGCTGCAAACAAGTCTACAATTTTTTAACTAGGCCACAATTTTTTAACCAAATTTAGAAATCAATTTAGTTACAAATAGGTAACTTTAAAAACTTCAGGCCAGGTACAGTGGCTCACACCTGTAAGCCCAGCACTTTGGGAGGCCGAGGGGGGCAGATCACGAGGTCAGGAGTTGGAGACCACCCTGGCTAACACAGTGAAACCCTGTCTCTACTAAAAATACAAAAAATTAGCCAGGCATGGTGGCGGGTGCCTGTAGTCCCAGCTACTCGGAAGGCTGAGGCAGGAGAATGGCGTGAACCCAGGAGGCAGAGCTTGCAGTGAGCCGAGATCGCGCCACTGCACTCCAGCCTGGGTGACAGAGCGAGACTCCGTCTCAAAAAAAAAAAAAAAAAAATTCAAACTTTTGAATTTGTAAATGTATATAGGTTCAGAAAGAGCTCAAAATGGAAGTTAGAAAATTTAAAACATGAAATATGTTACATATCAAAATTGGTACAGCTGGGCACAGTAACACACACCTATAATTCCACTAGGAAGGCTGAGGCAAGAGGATTCCTTGAGCCCAAGAGTTCAAGATCAGTTTGGGCAACTTAGCAAGACCTTATCTCTAAATACACACACACAGAGACACACAGACACACACACACACGTGTATATATATACATATATATACACACACATATATAATTACATATATACACACATATACAGTATATATACATATTTACACAAACACACACACATATATAGAGTGCAACTAAAGTGATATTTAGAGGGAAATTTATAGCCCTAAATGTACATATCAGACAATAAAATCAGTGCTGGAGAAAACCAAAAAATAAACTATCATGCTATTTTCCAATATGGTACATTCCAATGAAAGGAAGAGTCAATTGTTTCTCTGCATGTTTACTCTCTAATCAGAAAGTGGTTGGGTCATAAGGAAGAAAGATAACATATGTAAGTGTTTAGCTTTGGCAAGGGAACATCACTAATTGAATGTTTATGTAATTGAAATTAAAGAAGATTGAAATATTCATCTTTAGTGTTTTCTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCCAGGCTGGAGTGAAGCGGCACGATCACTGCTCACTGCAAGTTCTCCCTCCCGGGTTCACGCCATTCTCCTGTCTCAGCCTCCCAAGTAGCTGGAACTACAGGCACCCGCCACCACGCCTGGCTAATTTTCTGTATTTTTAGTAGAGACATGGTTTCACCATGTTAGCCAGGATGGTCTCAATCTCCTGACCTCATGATCCGCCTGCCTCGGCCTCCCAAAATGCTGGGATTACAGGGGTAAGCCACTGCGCCCAGCCTAGTGTTTTCACATTATCCATATTACTTTCTATTGCTCGTGAACACACACATGCACACACACATAAACTGGCCTTTTTGGATGGTGTGGAGGACCGACCACTCCATAGATTTTATCCACTCCACTGTAGTGGGCTGAGGAGGATCGACTCAAACTACCCAGCATTGACCAACCATCTGCCACGTGCAAGTTGCTACAGAGAATTCAAAGTTGAACGAAGTCAGCTTTGAGGAGCTCTAAGACCTGGTTTCACTAGAGGTCTAGGCATTGGAATGGAATGCAAAGAGATAAGGTTGGCAACATAAATTGAGGTGAGGTCACAGTGAGGCTTGAATGCCAGGGAAGGCATGTTAGTGAAGGTTTATGAGCAAGGAAATAAAAAGCATGGCCACACTTTAGGGAAATGGTATCCCAGAACATCTTACCTTCTTGGGTCATAAAGTCATCTTCAGCAAAGATGTTAAAGTTGCCACACAGCCCGCAGGTCTTGTTGAAGTATCTGTCTGACAGCAGGACTTGAAAGTTGCCGCTGCCATCGATCCTGGCCACAAAGCCATAGGCCTCACCGGACAGCTTGTAGTACCCAGCCTCAGTTTCTAGATACAGCCCTTTGGAGGCATAGGGCATGGAGACTCTGGAGGGCAAAGGCTAAGTTCAGAAGTGGGCTTCTTGTGCATTTTCTGGATGTCTCTCCCACCTTCTAACCCCAACCCCATGTTGTAGGGTTCAGAACATGGTGCAAAGTGGCTGAGGACCTAGATCAGCAATCGGGAGAGCTGGCTCTCACCCAGCCCTGCTACTCACTTCCTTGGAACATTTGCTTCCATTCTCTGGGCCCCAGCTTCCTCATCTAAAAATGAGGGGGTTGTGTCAGGGGATCCCTAGGGTCCTTTCTAACTCAGACATTGTTGGCTTACCTTTGGTCCCCCTGTGTCACGGTACCATTGACAAACAAATGGATGTCAAAAAATTCCCCAAGATACACGGAGAGGCTCACTCTCTTGCCATTCTGGAAGTCCCCTGAAAGAGAAAAAAGTCAATAGTAGTGATTATTACTCCTCTCAAAAAATGAATACATTGATTAAGAATCATTATCTACGTAACCTTTTCTCAGCAGAAAACGCCCCAAAAAGTCTTTACAAGCGAGCAACAAAAATCTCCCTAAAAATCTCATTTTCTCACCCATTTTTCCATTCATCTAAAAATAATTATTGAGTGACTTCTGGATACATTGCCCTCAGGTAGGCTCTCAAACATCACAAAAGAAAAATCTAAAAGCATGATCTTTTGCTTCTGGGAGTTTACAACCTGCGTATAAATAGAAGACAAACATGCGACAATTGAGTATATTGTAAGGCAGCAAACAAAAAGGCAACACTGTGAGTTACTGGTAACAGGTGCTCTAGGAGAGTGTTATTTATTCATTCATTCATTCACTTATTGAGACAGGGTTGTGCTCTGTTGCCCAGGTTGGGGTGCAGTGATGTGAACATGGCTCGCTGCAGTTTCTGCCTCCTGGGCCCAGGTTATCCTCCCACCTCAGCCTCCAGGGTAACTGGGATCACAAGTATGTACCACCACATCCAGCTAATTTTTTTTTTCTTTTTGTAGAGACAAGATCTCACCGTGTCGCCCAGGCTGGTCTTGAGCTCCTTGGTGCGAGTAATTACAGGCATGAGCCACCCCGCTCTGGCCTAGCAGTGCTATTTAAAATGGTATCGGTCGAGTGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGTGGATCACGAGGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCCGTCTCTACTAAAAATATGAAGAAAAAAAAAATTAGCCAGGCGAGGTGGCTGGCGTCTGTGGTCCCAGTTCTTTGGGAGGCTGAGGCAGAAGAACGGCGTGAACCCAGGAGGCGGAGCTTGCAGTGAGCGGAGATCGCGCCACTGCACTCCAGCCTGGGTGACAGAGCA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>ex4-5del</Name>
        <Name>8.6-KB DEL, EX4-5</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.6212487_6221117del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.6212487_6221117del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.6103321_6111951del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.6103321_6111951del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009072.2" sequenceAccession="NG_009072" sequenceVersion="2" change="g.17726_26356del">
            <Expression>NG_009072.2:g.17726_26356del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.5" sequenceAccession="NM_000552" sequenceVersion="5" change="c.221-977_532+7059del" MANESelect="true">
            <Expression>NM_000552.5:c.221-977_532+7059del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_587" sequenceAccession="LRG_587">
            <Expression>LRG_587:g.17726_26356del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_587t1" sequenceAccession="LRG_587t1">
            <Expression>LRG_587t1:c.221-977_532+7059del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613160.0038" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000552.5(VWF):c.221-977_532+7059del AND not provided" Accession="RCV000144413" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.221-977_532+7059del AND von Willebrand disease type 3" Accession="RCV002271340" Version="1">
        <ClassifiedConditionList TraitSetID="89">
          <ClassifiedCondition DB="MedGen" ID="C1264041">von Willebrand disease type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-07-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.221-977_532+7059del AND von Willebrand disease type 1" Accession="RCV002271339" Version="1">
        <ClassifiedConditionList TraitSetID="88">
          <ClassifiedCondition DB="MedGen" ID="C1264039">von Willebrand disease type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-07-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-07-30" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2014-10-06" MostRecentSubmission="2016-08-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19372260</ID>
        </Citation>
        <DescriptionHistory Dated="2022-07-30">
          <Description>not provided</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-30">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="88" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9626" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE I</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VWD, TYPE 1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 1</ElementValue>
                <XRef ID="von+Willebrand+disease%2C+type+1/9460" DB="Genetic Alliance" />
                <XRef ID="128106003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">autosomal recessive or autosomal dominant</Attribute>
                <XRef ID="GTR000502548" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083611</ID>
              </Citation>
              <XRef ID="166078" DB="Orphanet" />
              <XRef ID="903" DB="Orphanet" />
              <XRef ID="C1264039" DB="MedGen" />
              <XRef ID="MONDO:0008668" DB="MONDO" />
              <XRef Type="MIM" ID="193400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9627" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 3</ElementValue>
                <XRef ID="128108002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, recessive form</ElementValue>
                <XRef ID="Von+Willebrand+disease%2C+recessive+form/7419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 Von Willebrand's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 VWD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, severe form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">V WD3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE III</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD3</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="166096" DB="Orphanet" />
              <XRef ID="C1264041" DB="MedGen" />
              <XRef ID="MONDO:0010191" DB="MONDO" />
              <XRef Type="MIM" ID="277480" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50546" SubmissionDate="2016-08-04" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613160.0038_VON WILLEBRAND DISEASE, TYPE 3" title="VWF, 8.6-KB DEL, EX4-5_VON WILLEBRAND DISEASE, TYPE 3" />
        <ClinVarAccession Accession="SCV000045290" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-07-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 Caucasian British patients, including 2 sibs, with VWD type 3 (277480), Sutherland et al. (2009) identified a homozygous 8,631-bp deletion in the VWF gene, resulting in an in-frame deletion of exons 4 and 5. The deletion spanned from within intron 3 to within intron 5, and the breakpoints occurred in inverted AluY repeat elements. Analysis of other patients with VWD type 3 showed that 4 were compound heterozygous for the exon 4-5 deletion and another pathogenic mutation, and 1 was heterozygous for the deletion but with no second mutation detected. In total, 7 of 12 white patients with VWD type 3 carried this deletion, which was not found in 9 patients of Asian origin. Haplotype analysis confirmed a founder effect in the white British population. Heterozygosity for this deletion was found in 2 of 34 probands with VWD type 1 (193400), their affected family members, and 1 unaffected family member, indicating reduced penetrance. An unrelated patient with VWD type 1 was also found to carry a heterozygous deletion. In vitro functional expression studies showed that the deletion resulted in significantly decreased protein secretion, with a 98% decrease in the homozygous state and an 86% decrease in the heterozygous state, consistent with a dominant-negative effect. Expression of the homozygous mutation, but not of the heterozygous mutation, resulted in defective multimer production. The mutation was not found in 200 control alleles.</Attribute>
              <Citation>
                <ID Source="PubMed">19372260</ID>
              </Citation>
              <XRef DB="OMIM" ID="277480" Type="MIM" />
              <XRef DB="OMIM" ID="193400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <Name>VWF, 8.6-KB DEL, EX4-5</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8.6-KB DEL, EX4-5</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613160.0038" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VON WILLEBRAND DISEASE, TYPE 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="50547" SubmissionDate="2016-08-04" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613160.0038_VON WILLEBRAND DISEASE, TYPE 1" title="VWF, 8.6-KB DEL, EX4-5_VON WILLEBRAND DISEASE, TYPE 1" />
        <ClinVarAccession Accession="SCV000045291" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-07-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 Caucasian British patients, including 2 sibs, with VWD type 3 (277480), Sutherland et al. (2009) identified a homozygous 8,631-bp deletion in the VWF gene, resulting in an in-frame deletion of exons 4 and 5. The deletion spanned from within intron 3 to within intron 5, and the breakpoints occurred in inverted AluY repeat elements. Analysis of other patients with VWD type 3 showed that 4 were compound heterozygous for the exon 4-5 deletion and another pathogenic mutation, and 1 was heterozygous for the deletion but with no second mutation detected. In total, 7 of 12 white patients with VWD type 3 carried this deletion, which was not found in 9 patients of Asian origin. Haplotype analysis confirmed a founder effect in the white British population. Heterozygosity for this deletion was found in 2 of 34 probands with VWD type 1 (193400), their affected family members, and 1 unaffected family member, indicating reduced penetrance. An unrelated patient with VWD type 1 was also found to carry a heterozygous deletion. In vitro functional expression studies showed that the deletion resulted in significantly decreased protein secretion, with a 98% decrease in the homozygous state and an 86% decrease in the heterozygous state, consistent with a dominant-negative effect. Expression of the homozygous mutation, but not of the heterozygous mutation, resulted in defective multimer production. The mutation was not found in 200 control alleles.</Attribute>
              <Citation>
                <ID Source="PubMed">19372260</ID>
              </Citation>
              <XRef DB="OMIM" ID="277480" Type="MIM" />
              <XRef DB="OMIM" ID="193400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <Name>VWF, 8.6-KB DEL, EX4-5</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8.6-KB DEL, EX4-5</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613160.0038" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">VON WILLEBRAND DISEASE, TYPE 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="336711" SubmissionDate="2011-07-28" DateLastUpdated="2014-10-06" DateCreated="2014-10-06">
        <ClinVarSubmissionID localKey="NM_000552.3:c.221-977_532+7059del|NCBI-CURATED-RECORDS" />
        <ClinVarAccession Accession="SCV000189468" DateUpdated="2014-10-06" DateCreated="2014-10-06" Type="SCV" Version="1" SubmitterName="ClinVar Staff, National Center for Biotechnology Information (NCBI)" OrgID="500139" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>ex4-5del</Name>
            <Name>p.Asp75_Gly178del</Name>
          </OtherNameList>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">19372260</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.221-977_532+7059del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>mdi-4064</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50546" TraitType="Disease" MappingType="Name" MappingValue="VON WILLEBRAND DISEASE, TYPE 3" MappingRef="Preferred">
        <MedGen CUI="C1264041" Name="von Willebrand disease type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50547" TraitType="Disease" MappingType="Name" MappingValue="VON WILLEBRAND DISEASE, TYPE 1" MappingRef="Alternate">
        <MedGen CUI="C1264039" Name="von Willebrand disease type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="336711" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

